Video

Immunotherapy Brings 'Radical Change' to Lung Cancer Treatment

Marina Chiara Garassino, M.D., talks about how immunotherapy agents have vastly improved the treatment field of patients with non-small cell lung cancer.

Marina Chiara Garassino, M.D., medical consultant in the Medical Oncology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, talks about how immunotherapy agents have vastly improved the treatment field of patients with non-small cell lung cancer.

Over the past few years, there have been exciting advancements with the addition of anti-PD1 and anti-PD-L1 agents to the lung cancer space. Now, even more trials are investigating the use of immunotherapy in both the neoadjuvant and adjuvant settings.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.